Latest California Healthline Stories
Advocacy Group Pushes For Changes In U.S. Food Assistance Program
The Physicians Committee for Responsible Medicine, which eschews meat and pushes for nutrition to have a stronger influence in health policy, is suggesting alterations in how food aid to low income people is structured.
21 Medicare Health Plans Warned To Fix Provider Directory Errors
Federal officials release names of insurers who ranked poorly in a recent review of their online directories’ accuracy.
Foul-Up Means Thousands On State Exchange Surprised By Higher Premiums
Covered California sent the wrong subsidy information to insurers, who charged most consumers less than they really owed. Now they have to pay up.
Large Employer Health Plans Could Also See Some Impacts From Obamacare Overhaul
With the future of Obamacare on the line, workers might want to consider what benefits they have gained through the landmark law.
6 Lesser-Known Obamacare Provisions That Could Evaporate
Some lesser known provisions of the health law — things like calorie counts, lifetime limits and breast-feeding support — could be rolled back by repeal.
Sin Obamacare, ¿qué pasará con el seguro de salud a través de su empleo?
Si piensas que porque tienes seguro de salud a través de tu trabajo en una gran compañía, no te afectará si los republicanos cambian el Obamacare, piénsalo dos veces. Muchas de las provisiones de la ley también aplican a los planes ofrecidos por grandes empleadores.
Six U.S. Senators Confronting Trump’s HHS Cabinet Pick Own Health Care Stocks, Too
Donald Trump’s pick to run HHS has been under fire for trading health care stocks but at least six Senators at his confirmation hearings also own such stocks.
Budget Scorekeepers Say GOP Plan Would Raise The Number Of Uninsured By 32M
An analysis by the Congressional Budget Office offers an estimate of the effects of the repeal plan offered by congressional Republican in 2015, which may be a blueprint for efforts currently underway to overhaul the health law.
Sky-High Prices For Orphan Drugs Slam American Families And Insurers
Orphan drugs for rare diseases have helped or saved hundreds of thousands of patients like 2-year-old Luke Whitbeck, but families and insurers are picking up the astronomical cost.
Una investigación de Kaiser Health News analiza las acciones de compañias farmacéuticas para manipular los precios de medicamentos huérfanos, utilizados para tratar enfermedades raras.